|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
IN150740B
(ja)
|
1978-11-24 |
1982-12-04 |
Hoffmann La Roche |
|
|
US4760067A
(en)
|
1979-08-15 |
1988-07-26 |
Merck & Co., Inc. |
Allylsulfoxide enzyme inhibitors
|
|
EP0040506B1
(en)
|
1980-05-21 |
1986-08-20 |
Teijin Limited |
Reactive polymer and process for the preparation thereof
|
|
US4560649A
(en)
|
1981-10-15 |
1985-12-24 |
Cornell Research Foundation |
Assaying for hLH or hCG with immobilized hormone receptors
|
|
JPH0751511B2
(ja)
|
1982-03-15 |
1995-06-05 |
味の素株式会社 |
インターロイキン２を含有してなる癌治療剤
|
|
DE3378250D1
(en)
|
1982-04-22 |
1988-11-24 |
Ici Plc |
Continuous release formulations
|
|
US4587046A
(en)
|
1982-05-18 |
1986-05-06 |
The Regents Of The University Of California |
Drug-carrier conjugates
|
|
DE3380726D1
(en)
|
1982-06-24 |
1989-11-23 |
Japan Chem Res |
Long-acting composition
|
|
US4966888A
(en)
|
1985-07-08 |
1990-10-30 |
Cornell Research Foundation, Inc. |
hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
|
|
US4522750A
(en)
|
1984-02-21 |
1985-06-11 |
Eli Lilly And Company |
Cytotoxic compositions of transferrin coupled to vinca alkaloids
|
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
SE470099B
(sv)
|
1984-05-17 |
1993-11-08 |
Jerker Porath |
Sulfonaktiverade tioeteradsorbenter för separation av t ex protein
|
|
US4578335A
(en)
|
1984-05-21 |
1986-03-25 |
Immunex Corporation |
Interleukin 2 receptor
|
|
US4670563A
(en)
|
1984-06-20 |
1987-06-02 |
Sanofi |
Imidazolides as intermediates for the synthesis of cytotoxic conjugates
|
|
US4675285A
(en)
|
1984-09-19 |
1987-06-23 |
Genetics Institute, Inc. |
Method for identification and isolation of DNA encoding a desired protein
|
|
SE454885B
(sv)
|
1984-10-19 |
1988-06-06 |
Exploaterings Ab Tbf |
Polymerbelagda partiklar med immobiliserade metalljoner pa sin yta jemte forfarande for framstellning derav
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4917888A
(en)
|
1985-06-26 |
1990-04-17 |
Cetus Corporation |
Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
|
|
WO1987000056A1
(en)
|
1985-06-26 |
1987-01-15 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
JPS62185029A
(ja)
|
1986-02-07 |
1987-08-13 |
Ajinomoto Co Inc |
修飾インタ−ロイキン−２
|
|
CA1283046C
(en)
|
1986-05-29 |
1991-04-16 |
Nandini Katre |
Tumor necrosis factor formulation
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
IN165717B
(ja)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US4931544A
(en)
|
1986-09-04 |
1990-06-05 |
Cetus Corporation |
Succinylated interleukin-2 for pharmaceutical compositions
|
|
IL80005A
(en)
|
1986-09-10 |
1992-11-15 |
Yeda Res & Dev |
Compositions for modulating the effect of tnf and il-1
|
|
US4965271A
(en)
|
1986-12-31 |
1990-10-23 |
Hoechst Roussel Pharmaceuticals, Inc. |
Method of inhibiting the activity of leukocyte derived cytokines
|
|
US5359032A
(en)
|
1987-08-26 |
1994-10-25 |
Biogen Inc. |
Interkeukin-1 inhibitor
|
|
IL90339A
(en)
|
1989-05-18 |
1996-10-16 |
Yeda Res & Dev |
Anti-cytotoxic protein and its purification
|
|
IL98078A0
(en)
|
1991-05-07 |
1992-06-21 |
Yeda Res & Dev |
Pharmaceutical compositions comprising an anticytokyne
|
|
IL83878A
(en)
*
|
1987-09-13 |
1995-07-31 |
Yeda Res & Dev |
Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
|
|
US5512544A
(en)
|
1987-09-13 |
1996-04-30 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising an anticytokine
|
|
US4904584A
(en)
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
US5153265A
(en)
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
|
GB8806339D0
(en)
|
1988-03-17 |
1988-04-13 |
Hoffmann La Roche |
Monoclonal antibodies
|
|
GB8807803D0
(en)
|
1988-03-31 |
1988-05-05 |
Glaxo Group Ltd |
Biochemical product
|
|
US5256642A
(en)
|
1988-04-01 |
1993-10-26 |
The Johns Hopkins University |
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
|
|
IL89790A
(en)
|
1988-04-01 |
2002-05-23 |
Johns Hopking University |
Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification
|
|
US5214131A
(en)
|
1988-05-06 |
1993-05-25 |
Sumitomo Pharmaceuticals Company, Limited |
Polyethylene glycol derivatives, modified peptides and production thereof
|
|
US5075222A
(en)
|
1988-05-27 |
1991-12-24 |
Synergen, Inc. |
Interleukin-1 inhibitors
|
|
KR0148009B1
(ko)
|
1988-05-27 |
1998-08-01 |
그래고리 비. 아보트 |
인터루킨-1 억제제
|
|
JPH0240399A
(ja)
|
1988-07-27 |
1990-02-09 |
Takeda Chem Ind Ltd |
線維芽細胞増殖因子ムテインの複合体あるいは組成物
|
|
IL95064A0
(en)
*
|
1990-07-12 |
1991-06-10 |
Yeda Res & Dev |
Molecular cloning of tnf binding protein
|
|
US5811261A
(en)
|
1988-09-12 |
1998-09-22 |
Yeda Research And Development Co. Ltd. |
Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
|
|
IL94039A
(en)
|
1989-08-06 |
2006-09-05 |
Yeda Res & Dev |
Antibodies to tbp - 1 and their use
|
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
|
GB8824592D0
(en)
|
1988-10-20 |
1988-11-23 |
Royal Free Hosp School Med |
Purification process
|
|
US5681566A
(en)
|
1988-10-24 |
1997-10-28 |
3I Research Exploitation Limited |
Antibody conjugates with two or more covalently linked FC regions
|
|
GB8824869D0
(en)
|
1988-10-24 |
1988-11-30 |
Stevenson G T |
Synthetic antibody
|
|
US5162430A
(en)
|
1988-11-21 |
1992-11-10 |
Collagen Corporation |
Collagen-polymer conjugates
|
|
WO1990005534A1
(en)
|
1988-11-23 |
1990-05-31 |
Genentech, Inc. |
Polypeptide derivatives
|
|
WO1990006774A1
(en)
|
1988-12-22 |
1990-06-28 |
Xoma Corporation |
Hindered linking agents and methods
|
|
US4902502A
(en)
|
1989-01-23 |
1990-02-20 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
|
US5089261A
(en)
|
1989-01-23 |
1992-02-18 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
EP0386289A1
(en)
|
1989-03-07 |
1990-09-12 |
Taniguchi, Tadatsugu, Dr. |
Recombinant interleukin-2 receptor
|
|
CA2011450C
(en)
|
1989-03-07 |
2002-06-04 |
Tadatsugu Taniguchi |
Recombinant b-chain of the il-2 receptor
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
JPH03164179A
(ja)
*
|
1989-04-21 |
1991-07-16 |
Boehringer Ingelheim Internatl Gmbh |
Ｔｎｆレセプター、ｔｎｆ結合たん白質およびこれらをコードするｄｎａ
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
ATE289350T1
(de)
*
|
1989-04-21 |
2005-03-15 |
Amgen Inc |
Tnf-rezeptor, tnf bindende proteine und dafür kodierende dnas
|
|
US7264944B1
(en)
*
|
1989-04-21 |
2007-09-04 |
Amgen Inc. |
TNF receptors, TNF binding proteins and DNAs coding for them
|
|
DE3922089A1
(de)
|
1989-05-09 |
1990-12-13 |
Basf Ag |
Neue proteine und ihre herstellung
|
|
CA2017025C
(en)
*
|
1989-05-18 |
2008-07-22 |
David Wallach |
Tumor necrosis factor binding protein ii, its purification and antibodies thereto
|
|
IL95031A
(en)
*
|
1989-07-18 |
2007-03-08 |
Amgen Inc |
A method of producing a recombinant human necrotic factor absorber
|
|
US6143866A
(en)
*
|
1989-07-18 |
2000-11-07 |
Amgen, Inc. |
Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
NZ235148A
(en)
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
|
US5395760A
(en)
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
|
CA2065346C
(en)
|
1989-09-05 |
2005-03-29 |
Craig A. Smith |
Tumor necrosis factor-.alpha. and-.beta. receptors
|
|
DK0417563T3
(da)
|
1989-09-12 |
2000-11-06 |
Hoffmann La Roche |
TNF-bindende proteiner
|
|
US5350836A
(en)
*
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
|
US5234903A
(en)
|
1989-11-22 |
1993-08-10 |
Enzon, Inc. |
Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
|
|
EP0502956B1
(en)
|
1989-11-29 |
1997-04-23 |
Amgen Boulder Inc. |
Production of recombinant human interleukin-1 inhibitor
|
|
EP0433900B1
(en)
*
|
1989-12-13 |
1995-09-20 |
Yeda Research And Development Company Limited |
Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
|
|
US5136021A
(en)
|
1990-02-27 |
1992-08-04 |
Health Research, Inc. |
TNF-inhibitory protein and a method of production
|
|
US5171264A
(en)
|
1990-02-28 |
1992-12-15 |
Massachusetts Institute Of Technology |
Immobilized polyethylene oxide star molecules for bioapplications
|
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
|
US6458360B1
(en)
|
1990-04-25 |
2002-10-01 |
The Johns Hopkins University |
Soluble complement regulatory molecules
|
|
GB2246569A
(en)
|
1990-06-15 |
1992-02-05 |
Charing Cross Sunley Research |
Tumour necrosis factor - alpha binding protein
|
|
WO1992001002A1
(fr)
|
1990-07-11 |
1992-01-23 |
Teijin Limited |
Inhibiteur de l'activite du facteur de la necrose tumorale et son procede de preparation
|
|
GB9015908D0
(en)
|
1990-07-19 |
1990-09-05 |
Celltech Ltd |
Multivalent immunoglobulin
|
|
AU657483B2
(en)
|
1990-07-20 |
1995-03-16 |
Pharmacia Ab |
Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures
|
|
EP0687691B1
(en)
|
1990-08-31 |
1998-10-07 |
Regents Of The University Of Minnesota |
Resin for solid-phase peptide synthesis
|
|
GB9022648D0
(en)
|
1990-10-18 |
1990-11-28 |
Charing Cross Sunley Research |
Polypeptide and its use
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
DK0567566T4
(da)
|
1991-01-18 |
2007-10-22 |
Amgen Inc |
Fremgangsmåder til behandling af tumornekrosefaktor-medierede sygdomme
|
|
JPH06508985A
(ja)
|
1991-02-27 |
1994-10-13 |
クリエイティブ バイオモレキュルズ インコーポレイテッド |
富セリンペプチドリンカー
|
|
ES2199935T3
(es)
*
|
1991-03-15 |
2004-03-01 |
Amgen Inc. |
Pegilacion de polipeptidos.
|
|
AU1676992A
(en)
|
1991-03-18 |
1992-10-21 |
Enzon, Inc. |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
|
JP3340434B2
(ja)
|
1991-07-04 |
2002-11-05 |
ダコ アクティーゼルスカブ |
ジビニルスルホンに由来する成分を含んで成る水溶性ポリマーベース試薬及び抱合体
|
|
IL99120A0
(en)
*
|
1991-08-07 |
1992-07-15 |
Yeda Res & Dev |
Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
|
|
US5569779A
(en)
|
1991-12-23 |
1996-10-29 |
Albemarle Corporation |
Polyfunctional michael addition products
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
JPH08502082A
(ja)
|
1992-07-02 |
1996-03-05 |
コラーゲン コーポレイション |
生体適合性ポリマー結合体
|
|
US5382657A
(en)
|
1992-08-26 |
1995-01-17 |
Hoffmann-La Roche Inc. |
Peg-interferon conjugates
|
|
NZ256293A
(en)
|
1992-09-15 |
1997-06-24 |
Immunex Corp |
Method of treating tumour necrosis factor - mediated inflammation by use of tnf antagonist
|
|
US6270766B1
(en)
|
1992-10-08 |
2001-08-07 |
The Kennedy Institute Of Rheumatology |
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
|
|
EP0622394A1
(en)
|
1993-04-30 |
1994-11-02 |
S.A. Laboratoires S.M.B. |
Reversible modification of sulfur-containing molecules with polyalkylene glycol derivatives and their use
|
|
JPH09509646A
(ja)
|
1993-07-30 |
1997-09-30 |
ケネディー インスティチュート オブ リューマトロジー |
多発性硬化症を治療する方法
|
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
JPH09508140A
(ja)
*
|
1994-07-22 |
1997-08-19 |
エフ・ホフマン−ラ ロシュ アーゲー |
キメラｔｎｆ結合タンパク質を含有する医薬組成物
|
|
DE4441446A1
(de)
*
|
1994-11-22 |
1996-05-23 |
Ulrich Theis |
Verfahren zur Übergabe von Wäschestücken und vorzugsweise zur Durchführung des Verfahrens dienende Muldenmangel
|
|
TW313568B
(ja)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
|
US7429646B1
(en)
*
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
|
US5747639A
(en)
|
1996-03-06 |
1998-05-05 |
Amgen Boulder Inc. |
Use of hydrophobic interaction chromatography to purify polyethylene glycols
|
